CLINICAL TRIALS PROFILE FOR JUNIOR STRENGTH ADVIL
✉ Email this page to a colleague
All Clinical Trials for Junior Strength Advil
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00435500 ↗ | Fluoride Varnish in the Prevention of Dental Caries in Aboriginal and Non-aboriginal Children | Unknown status | Canadian Institutes of Health Research (CIHR) | Phase 3 | 2003-06-01 | The purpose of this study is to determine whether semi-annual fluoride varnish applications combined with caregiver counseling are effective in preventing and reducing a severe form of dental decay, known as early childhood caries, in native and non-native children aged 6 months to 5 years. |
NCT00435500 ↗ | Fluoride Varnish in the Prevention of Dental Caries in Aboriginal and Non-aboriginal Children | Unknown status | The Hospital for Sick Children | Phase 3 | 2003-06-01 | The purpose of this study is to determine whether semi-annual fluoride varnish applications combined with caregiver counseling are effective in preventing and reducing a severe form of dental decay, known as early childhood caries, in native and non-native children aged 6 months to 5 years. |
NCT00435500 ↗ | Fluoride Varnish in the Prevention of Dental Caries in Aboriginal and Non-aboriginal Children | Unknown status | University of Toronto | Phase 3 | 2003-06-01 | The purpose of this study is to determine whether semi-annual fluoride varnish applications combined with caregiver counseling are effective in preventing and reducing a severe form of dental decay, known as early childhood caries, in native and non-native children aged 6 months to 5 years. |
NCT00931398 ↗ | Treatment of College Students With Attention-Deficit/Hyperactivity Disorder (ADHD) Using OROS Methylphenidate | Withdrawn | Ortho-McNeil Janssen Scientific Affairs, LLC | Phase 4 | 2010-04-01 | The purpose of the proposed study is to determine the effectiveness of methylphenidate HCl (Concerta) in college students with ADHD. This study will consist of 110 college students between the ages of 18 and 25 who are enrolled full-time in a local or junior college. The study consists of an 8-week double-blind, placebo-controlled trial of placebo versus methylphenidate HCl (Concerta®) followed by a 10-week extension of open label methylphenidate HCl (Concerta®). |
NCT00931398 ↗ | Treatment of College Students With Attention-Deficit/Hyperactivity Disorder (ADHD) Using OROS Methylphenidate | Withdrawn | University of Pittsburgh | Phase 4 | 2010-04-01 | The purpose of the proposed study is to determine the effectiveness of methylphenidate HCl (Concerta) in college students with ADHD. This study will consist of 110 college students between the ages of 18 and 25 who are enrolled full-time in a local or junior college. The study consists of an 8-week double-blind, placebo-controlled trial of placebo versus methylphenidate HCl (Concerta®) followed by a 10-week extension of open label methylphenidate HCl (Concerta®). |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Junior Strength Advil
Condition Name
Clinical Trial Locations for Junior Strength Advil
Trials by Country
Clinical Trial Progress for Junior Strength Advil
Clinical Trial Phase
Clinical Trial Sponsors for Junior Strength Advil
Sponsor Name